Medtech grants in Poland

Closed

Funds bottom-up research for breakthrough deep-tech, any field of science.

Closed

Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.

Closed

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds up to two projects that design AI-in-health training programmes jointly with universities, VET providers, hospitals and industry, delivered through Europe's AI screening-centre network.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.

Closed

Funds AI teams building generative-AI tools for clinical-dataset enhancement or automotive crash-test case generation, paying up to €100,000 in prizes after an initial €28,500 concept-stage award.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Closed

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds hospital consortia to pilot cloud-based AI systems that read medical scans for cancer and cardiovascular screening, with clinicians validating every result.

Closed

Funds research into unmanned vehicles that can find, assess and evacuate wounded soldiers in mass-casualty and CBRN combat zones.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Pays 200,000 euros to study bioengineering business ideas that use microgravity.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.

Closed

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Closed

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Closed

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Closed

Funds public-private research that connects fragmented health R&I efforts into shared tools, data, platforms and manufacturing processes.

Closed

Funds public-private research on interoperable health data and AI analytics that speed up diagnosis, treatment and personalised care.

Closed

Funds one consortium EUR 24.4 million to run a programme that re-grants up to EUR 120,000 each to hospitals, public authorities and health-data holders across the EU.

Closed

Funds a stepwise rollout of gastric cancer screening programmes across EU Member States, including AI-assisted screening.

Closed

Funds research and low-carbon medical technology that cuts the health sector's own emissions while making healthcare systems and communities more resilient to climate change.

Closed

Funds coordination of European nuclear research platforms across energy, medicine, space, maritime uses and radiation protection.

Closed

Funds pilot projects that assess hospital cybersecurity gaps and demonstrate detection and response tools at partner healthcare sites in at least two member states.